Richard D. Francis, President and CEO of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 250,000 shares of the company's stock on November 12, 2026. The transaction, executed at a price of $42.24 per share, amounted to approximately $10.56 million.
This sale follows other recent insider selling activity within TEVA. On the same day, Sabag Mark sold 44,710 shares for roughly $1.97 million. The prior day, November 11, 2026, Daniell Richard sold 20,003 shares valued at approximately $856,128.
Insider sales can be driven by various factors including portfolio diversification, tax obligations, or pre-arranged trading plans and do not necessarily reflect a negative outlook on the company's future performance.